Seeing Is Believing
with an average price target of $58.25. This is a potential upside of $41.55 (248.8%) from yesterday's end of day stock price of $16.7.
Orchard Therapeutics PLC's activity chart (see below) currently has 38 price targets and 34 ratings on display.
Analysts average stock forecasts to be materialized ratio is 35.26% with an average time for these price targets to be met of 115.46 days.
Most recent stock forecast was given by DAE GON HA from STIFEL on 04-Oct-2023. First documented stock forecast 25-Nov-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$16
$-0.7 (-4.19%)
$22
2 years 8 days ago
(04-Oct-2023)
1/2 (50%)
$0.05 (0.31%)
1
Buy
$15
$-1.7 (-10.18%)
$15
2 years 3 months 16 days ago
(26-Jun-2023)
2/2 (100%)
$9.77 (186.81%)
146
Buy
2 years 4 months ago
(12-Jun-2023)
1/2 (50%)
$88 (107.32%)
428
Buy
$5
$-11.7 (-70.06%)
2 years 7 months ago
(12-Mar-2023)
1/1 (100%)
$0.05 (1.01%)
1
Buy
$13
3 years 5 months ago
(12-May-2022)
1/2 (50%)
$-34.2 (-72.46%)
481
What is ORTX (Orchard Therapeutics PLC) average time for price targets to be met?
Which analyst has the current highest performing score on ORTX (Orchard Therapeutics PLC) with a proven track record?
Which analyst has the most public recommendations on ORTX (Orchard Therapeutics PLC)?
Which analyst is the currently most bullish on ORTX (Orchard Therapeutics PLC)?
Which analyst is the currently most reserved on ORTX (Orchard Therapeutics PLC)?